Interleukin-12 family members and type i interferons in Th17-mediated inflammatory disorders

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 64, Issue 5, 2009, Pages 702-709

  Goriely, S ^a   Cavoy, R ^a   Goldman, M ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

Autoimmunity; Inteferon; Interleukin 27; Regulatory T cells; T helper 17

Indexed keywords

CYTOKINE; INTERFERON; INTERLEUKIN 12; INTERLEUKIN 23; INTERLEUKIN 27;

ALLERGY; AUTOIMMUNITY; HUMAN; IN VITRO STUDY; INFLAMMATORY DISEASE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; TH17 CELL;

ANIMALS; ANTIGEN-PRESENTING CELLS; AUTOIMMUNE DISEASES; AUTOIMMUNITY; HUMANS; HYPERSENSITIVITY; INFLAMMATION; INTERFERON TYPE I; INTERLEUKIN-12; INTERLEUKIN-17; INTERLEUKIN-23; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 63849241638     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2009.02039.x     Document Type: Review

References (97)

1. Gutcher I, Becher B. APC-derived cytokines and T cell polarization in autoimmune inflammation. J Clin Invest 2007 117 : 1119 1127.
2. Weaver CT, Hatton RD, Mangan PR, Harrington LE. IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu Rev Immunol 2007 25 : 821 852.
3. Cua DJ, Sherlock J, Chen Y, Murphy CA, Joyce B, Seymour B et al. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 2003 421 : 744 748.
4. Duerr RH, Taylor KD, Brant SR, Rioux JD, Silverberg MS, Daly MJ et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 2006 314 : 1461 1463.
5. Yen D, Cheung J, Scheerens H, Poulet F, McClanahan T, McKenzie B et al. IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6. J Clin Invest 2006 116 : 1310 1316.
6. Lee E, Trepicchio WL, Oestreicher JL, Pittman D, Wang F, Chamian F et al. Increased expression of interleukin 23 p19 and p40 in lesional skin of patients with psoriasis vulgaris. J Exp Med 2004 199 : 125 130.
7. McGeachy MJ, Cua DJ. Th17 cell differentiation: the long and winding road. Immunity 2008 28 : 445 453.
8. Dong C. TH17 cells in development: an updated view of their molecular identity and genetic programming. Nat Rev Immunol 2008 8 : 337 348.
9. Romagnani S. Human Th17 cells. Arthritis Res Ther 2008 10 : 206.
10. Veldhoen M, Hocking RJ, Atkins CJ, Locksley RM, Stockinger B. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 2006 24 : 179 189.
11. McGeachy MJ, Bak-Jensen KS, Chen Y, Tato CM, Blumenschein W, McClanahan T et al. TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology. Nat Immunol 2007 8 : 1390 1397.
12. Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, Oukka M et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006 441 : 235 238.
13. Ivanov II, McKenzie BS, Zhou L, Tadokoro CE, Lepelley A, Lafaille JJ et al. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17(+) T helper cells. Cell 2006 126 : 1121 1133.
14. Zhou L, Ivanov II, Spolski R, Min R, Shenderov K, Egawa T et al. IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat Immunol 2007.
15. Korn T, Bettelli E, Gao W, Awasthi A, Jager A, Strom TB et al. IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells. Nature 2007 448 : 484 487.
16. Acosta-Rodriguez EV, Rivino L, Geginat J, Jarrossay D, Gattorno M, Lanzavecchia A et al. Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nat Immunol 2007 8 : 639 646.
17. Wilson NJ, Boniface K, Chan JR, McKenzie BS, Blumenschein WM, Mattson JD et al. Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat Immunol 2007 8 : 950 957.
18. Annunziato F, Cosmi L, Santarlasci V, Maggi L, Liotta F, Mazzinghi B et al. Phenotypic and functional features of human Th17 cells. J Exp Med 2007 204 : 1849 1861.
19. Harrington LE, Hatton RD, Mangan PR, Turner H, Murphy TL, Murphy KM et al. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 2005 6 : 1123 1132.
20. Korn T, Reddy J, Gao W, Bettelli E, Awasthi A, Petersen TR et al. Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation. Nat Med 2007 13 : 423 431.
21. Lohr J, Knoechel B, Wang JJ, Villarino AV, Abbas AK. Role of IL-17 and regulatory T lymphocytes in a systemic autoimmune disease. J Exp Med 2006 203 : 2785 2791.
22. Kroenke MA, Carlson TJ, Andjelkovic AV, Segal BM. IL-12- and IL-23-modulated T cells induce distinct types of EAE based on histology, CNS chemokine profile, and response to cytokine inhibition. J Exp Med 2008 205 : 1535 1541.
23. Luger D, Silver PB, Tang J, Cua D, Chen Z, Iwakura Y et al. Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category. J Exp Med 2008 205 : 799 810.
24. Chen Y, Langrish CL, McKenzie B, Joyce-Shaikh B, Stumhofer JS, McClanahan T et al. Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis. J Clin Invest 2006 116 : 1317 1326.
25. Kullberg MC, Jankovic D, Feng CG, Hue S, Gorelick PL, McKenzie BS et al. IL-23 plays a key role in Helicobacter hepaticus-induced T cell-dependent colitis. J Exp Med 2006 203 : 2485 2494.
26. O'Connor RA, Prendergast CT, Sabatos CA, Lau CW, Leech MD, Wraith DC et al. Cutting Edge: Th1 cells facilitate the entry of Th17 cells to the central nervous system during experimental autoimmune encephalomyelitis. J Immunol 2008 181 : 3750 3754.
27. Oboki K, Ohno T, Saito H, Nakae S. Th17 and allergy. Allergol Int 2008 57 : 121 134.
28. Gran B, Zhang GX, Yu S, Li J, Chen XH, Ventura ES et al. IL-12p35-deficient mice are susceptible to experimental autoimmune encephalomyelitis: evidence for redundancy in the IL-12 system in the induction of central nervous system autoimmune demyelination. J Immunol 2002 169 : 7104 7110.
29. Wang Z, Hong J, Sun W, Xu G, Li N, Chen X et al. Role of IFN-gamma in induction of Foxp3 and conversion of CD4+. J Clin Invest 2006 116 : 2434 2441.
30. Nurieva R, Yang XO, Martinez G, Zhang Y, Panopoulos AD, Ma L et al. Essential autocrine regulation by IL-21 in the generation of inflammatory T cells. Nature 2007 448 : 480 483.
31. Rangachari M, Mauermann N, Marty RR, Dirnhofer S, Kurrer MO, Komnenovic V et al. T-bet negatively regulates autoimmune myocarditis by suppressing local production of interleukin 17. J Exp Med 2006 203 : 2009 2019.
32. Lin W, Bailey SL, Ho H, Harding HP, Ron D, Miller SD et al. The integrated stress response prevents demyelination by protecting oligodendrocytes against immune-mediated damage. J Clin Invest 2007 117 : 448 456.
33. Sawitzki B, Kingsley CI, Oliveira V, Karim M, Herber M, Wood KJ. IFN-gamma production by alloantigen-reactive regulatory T cells is important for their regulatory function in vivo. J Exp Med 2005 201 : 1925 1935.
34. Wood KJ, Sawitzki B. Interferon gamma: a crucial role in the function of induced regulatory T cells in vivo. Trends Immunol 2006 27 : 183 187.
35. Villarino A, Hibbert L, Lieberman L, Wilson E, Mak T, Yoshida H et al. The IL-27R (WSX-1) is required to suppress T cell hyperactivity during infection. Immunity 2003 19 : 645 655.
36. Miyazaki Y, Inoue H, Matsumura M, Matsumoto K, Nakano T, Tsuda M et al. Exacerbation of experimental allergic asthma by augmented Th2 responses in WSX-1-deficient mice. J Immunol 2005 175 : 2401 2407.
37. Rosas LE, Satoskar AA, Roth KM, Keiser TL, Barbi J, Hunter C et al. Interleukin-27R (WSX-1/T-cell cytokine receptor) gene-deficient mice display enhanced resistance to Leishmania donovani infection but develop severe liver immunopathology. Am J Pathol 2006 168 : 158 169.
38. Holscher C, Holscher A, Ruckerl D, Yoshimoto T, Yoshida H, Mak T et al. The IL-27 receptor chain WSX-1 differentially regulates antibacterial immunity and survival during experimental tuberculosis. J Immunol 2005 174 : 3534 3544.
39. Batten M, Li J, Yi S, Kljavin NM, Danilenko DM, Lucas S et al. Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells. Nat Immunol 2006 7 : 929 936.
40. Stumhofer JS, Laurence A, Wilson EH, Huang E, Tato CM, Johnson LM et al. Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system. Nat Immunol 2006 7 : 937 945.
41. Fitzgerald DC, Ciric B, Touil T, Harle H, Grammatikopolou J, Das SJ et al. Suppressive effect of IL-27 on encephalitogenic Th17 cells and the effector phase of experimental autoimmune encephalomyelitis. J Immunol 2007 179 : 3268 3275.
42. Niedbala W, Cai B, Wei X, Patakas A, Leung BP, McInnes IB et al. Interleukin-27 attenuates collagen-induced arthritis. Ann Rheum Dis 2008 181 : 4780 4790.
43. Amadi-Obi A, Yu CR, Liu X, Mahdi RM, Clarke GL, Nussenblatt RB et al. T(H)17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1. Nat Med 2007 13 : 711 718.
44. Sugiyama N, Nakashima H, Yoshimura T, Sadanaga A, Shimizu S, Masutani K et al. Amelioration of human lupus-like phenotypes in MRL/lpr mice by overexpression of IL-27R[alpha] (WSX-1). Ann Rheum Dis 2008 67 : 1461 1467.
45. Villarino AV, Stumhofer JS, Saris CJ, Kastelein RA, de Sauvage FJ, Hunter CA. IL-27 limits IL-2 production during Th1 differentiation. J Immunol 2006 176 : 237 247.
46. Stumhofer JS, Silver JS, Laurence A, Porrett PM, Harris TH, Turka LA et al. Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10. Nat Immunol 2007 8 : 1363 1371.
47. Awasthi A, Carrier Y, Peron JP, Bettelli E, Kamanaka M, Flavell RA et al. A dominant function for interleukin 27 in generating interleukin 10-producing anti-inflammatory T cells. Nat Immunol 2007 8 : 1380 1389.
48. Fitzgerald DC, Zhang GX, El Behi M, Fonseca-Kelly Z, Li H, Yu S et al. Suppression of autoimmune inflammation of the central nervous system by interleukin 10 secreted by interleukin 27-stimulated T cells. Nat Immunol 2007 8 : 1372 1379.
49. Batten M, Kljavin NM, Li J, Walter MJ, De Sauvage FJ, Ghilardi N. Cutting edge: IL-27 is a potent inducer of IL-10 but not FoxP3 in murine T Cells. J Immunol 2008 180 : 2752 2756.
50. Wirtz S, Tubbe I, Galle PR, Schild HJ, Birkenbach M, Blumberg RS et al. Protection from lethal septic peritonitis by neutralizing the biological function of interleukin 27. J Exp Med 2006 203 : 1875 1881.
51. Stock P, Akbari O, Berry G, Freeman GJ, DeKruyff RH, Umetsu DT. Induction of T helper type 1-like regulatory cells that express Foxp3 and protect against airway hyper-reactivity. Nat Immunol 2004 5 : 1149 1156.
52. Mascarell L, Lombardi V, Louise A, Saint-Lu N, Chabre H, Moussu H et al. Oral dendritic cells mediate antigen-specific tolerance by stimulating TH1 and regulatory CD4+ T cells. J Allergy Clin Immunol 2008 122 : 603 609.
53. Van Overtvelt L, Wambre E, Maillere B, Von Hofe E, Louise A, Balazuc AM et al. Assessment of Bet v 1-specific CD4+ T cell responses in allergic and nonallergic individuals using MHC class II peptide tetramers. J Immunol 2008 180 : 4514 4522.
54. Cosmi L, Santarlasci V, Angeli R, Liotta F, Maggi L, Frosali F et al. Sublingual immunotherapy with Dermatophagoides monomeric allergoid down-regulates allergen-specific immunoglobulin E and increases both interferon-gamma- and interleukin-10-production. Clin Exp Allergy 2006 36 : 261 272.
55. Honda K, Nakamura K, Matsui N, Takahashi M, Kitamura Y, Mizutani T et al. T helper 1-inducing property of IL-27/WSX-1 signaling is required for the induction of experimental colitis. Inflamm Bowel Dis 2005 11 : 1044 1052.
56. Villarino AV, Artis D, Bezbradica JS, Miller O, Saris CJ, Joyce S et al. IL-27R deficiency delays the onset of colitis and protects from helminth-induced pathology in a model of chronic IBD. Int Immunol 2008 20 : 739 752.
57. Siebler J, Wirtz S, Frenzel C, Schuchmann M, Lohse AW, Galle PR et al. Cutting edge: a key pathogenic role of IL-27 in T cell-mediated hepatitis. J Immunol 2008 180 : 30 33.
58. Cao Y, Doodes PD, Glant TT, Finnegan A. IL-27 induces a Th1 immune response and susceptibility to experimental arthritis. J Immunol 2008 180 : 922 930.
59. Neufert C, Becker C, Wirtz S, Fantini MC, Weigmann B, Galle PR et al. IL-27 controls the development of inducible regulatory T cells and Th17 cells via differential effects on STAT1. Eur J Immunol 2007 37 : 1809 1816.
60. Baccala R, Kono DH, Theofilopoulos AN. Interferons as pathogenic effectors in autoimmunity. Immunol Rev 2005 204 : 9 26.
61. Qing X, Putterman C. Gene expression profiling in the study of the pathogenesis of systemic lupus erythematosus. Autoimmun Rev 2004 3 : 505 509.
62. Hron JD, Peng SL. Type I IFN protects against murine lupus. J Immunol 2004 173 : 2134 2142.
63. Wu X, Peng SL. Toll-like receptor 9 signaling protects against murine lupus. Arthritis Rheum 2006 54 : 336 342.
64. Blanco P, Palucka AK, Gill M, Pascual V, Banchereau J. Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus. Science 2001 294 : 1540 1543.
65. Ronnblom L, Alm GV. A pivotal role for the natural interferon alpha-producing cells (plasmacytoid dendritic cells) in the pathogenesis of lupus. J Exp Med 2001 194 : F59 F63.
66. Colonna M, Trinchieri G, Liu YJ. Plasmacytoid dendritic cells in immunity. Nat Immunol 2004 5 : 1219 1226.
67. Ito T, Wang YH, Liu YJ. Plasmacytoid dendritic cell precursors/type I interferon-producing cells sense viral infection by toll-like receptor (TLR) 7 and TLR9. Springer Semin Immunopathol 2005 26 : 221 229.
68. Krug A, Towarowski A, Britsch S, Rothenfusser S, Hornung V, Bals R et al. Toll-like receptor expression reveals CpG DNA as a unique microbial stimulus for plasmacytoid dendritic cells which synergizes with CD40 ligand to induce high amounts of IL-12. Eur J Immunol 2001 31 : 3026 3037.
69. Bauer S, Kirschning CJ, Hacker H, Redecke V, Hausmann S, Akira S et al. Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition. Proc Natl Acad Sci USA 2001 98 : 9237 9242.
70. Haas T, Metzger J, Schmitz F, Heit A, Muller T, Latz E et al. The DNA sugar backbone 2' deoxyribose determines toll-like receptor 9 activation. Immunity 2008 28 : 315 323.
71. Lund JM, Alexopoulou L, Sato A, Karow M, Adams NC, Gale NW et al. Recognition of single-stranded RNA viruses by toll-like receptor 7. Proc Natl Acad Sci USA 2004 101 : 5598 5603.
72. Tian J, Avalos AM, Mao SY, Chen B, Senthil K, Wu H et al. Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE. Nat Immunol 2007 8 : 487 496.
73. Lande R, Gregorio J, Facchinetti V, Chatterjee B, Wang YH, Homey B et al. Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide. Nature 2007 449 : 564 569.
74. Banchereau J, Pascual V. Type I interferon in systemic lupus erythematosus and other autoimmune diseases. Immunity 2006 25 : 383 392.
75. Lang KS, Recher M, Junt T, Navarini AA, Harris NL, Freigang S et al. Toll-like receptor engagement converts T-cell autoreactivity into overt autoimmune disease. Nat Med 2005 11 : 138 145.
76. Lang KS, Georgiev P, Recher M, Navarini AA, Bergthaler A, Heikenwalder M et al. Immunoprivileged status of the liver is controlled by toll-like receptor 3 signaling. J Clin Invest 2006 116 : 2456 2463.
77. Stewart TA, Hultgren B, Huang X, Pitts-Meek S, Hully J, MacLachlan NJ. Induction of type I diabetes by interferon-alpha in transgenic mice. Science 1993 260 : 1942 1946.
78. Sobel DO, Ahvazi B. Alpha-interferon inhibits the development of diabetes in NOD mice. Diabetes 1998 47 : 1867 1872.
79. Sobel DO, Goyal D, Ahvazi B, Yoon JW, Chung YH, Bagg A et al. Low dose poly I:C prevents diabetes in the diabetes prone BB rat. J Autoimmun 1998 11 : 343 352.
80. Billiau A. Anti-inflammatory properties of type I interferons. Antiviral Res 2006 71 : 108 116.
81. Buttmann M, Rieckmann P. Interferon-beta1b in multiple sclerosis. Expert Rev Neurother 2007 7 : 227 239.
82. Teige I, Treschow A, Teige A, Mattsson R, Navikas V, Leanderson T et al. IFN-beta gene deletion leads to augmented and chronic demyelinating experimental autoimmune encephalomyelitis. J Immunol 2003 170 : 4776 4784.
83. Guo B, Chang EY, Cheng G. The type I IFN induction pathway constrains Th17-mediated autoimmune inflammation in mice. J Clin Invest 2008 118 : 1680 1690.
84. Touil T, Fitzgerald D, Zhang GX, Rostami A, Gran B. Cutting edge: TLR3 stimulation suppresses experimental autoimmune encephalomyelitis by inducing endogenous IFN-beta. J Immunol 2006 177 : 7505 7509.
85. Bailey-Bucktrout SL, Caulkins SC, Goings G, Fischer JA, Dzionek A, Miller SD. Cutting edge: central nervous system plasmacytoid dendritic cells regulate the severity of relapsing experimental autoimmune encephalomyelitis. J Immunol 2008 180 : 6457 6461.
86. Van Holten J, Reedquist K, Sattonet-Roche P, Smeets TJ, Plater-Zyberk C, Vervoordeldonk MJ et al. Treatment with recombinant interferon-beta reduces inflammation and slows cartilage destruction in the collagen-induced arthritis model of rheumatoid arthritis. Arthritis Res Ther 2004 6 : R239 R249.
87. Yarilina A, DiCarlo E, Ivashkiv LB. Suppression of the effector phase of inflammatory arthritis by double-stranded RNA is mediated by type I IFNs. J Immunol 2007 178 : 2204 2211.
88. Katakura K, Lee J, Rachmilewitz D, Li G, Eckmann L, Raz E. Toll-like receptor 9-induced type I IFN protects mice from experimental colitis. J Clin Invest 2005 115 : 695 702.
89. Obermeier F, Dunger N, Deml L, Herfarth H, Scholmerich J, Falk W. CpG motifs of bacterial DNA exacerbate colitis of dextran sulfate sodium-treated mice. Eur J Immunol 2002 32 : 2084 2092.
90. Kozovska ME, Hong J, Zang YC, Li S, Rivera VM, Killian JM et al. Interferon beta induces T-helper 2 immune deviation in MS. Neurology 1999 53 : 1692 1697.
91. Treschow AP, Teige I, Nandakumar KS, Holmdahl R, Issazadeh-Navikas S. Stromal cells and osteoclasts are responsible for exacerbated collagen-induced arthritis in interferon-beta-deficient mice. Arthritis Rheum 2005 52 : 3739 3748.
92. Takayanagi H, Kim S, Taniguchi T. Signaling crosstalk between RANKL and interferons in osteoclast differentiation. Arthritis Res 2002 4 (Suppl. 3 S227 S232.
93. Prinz M, Schmidt H, Mildner A, Knobeloch KP, Hanisch UK, Raasch J et al. Distinct and nonredundant in vivo functions of IFNAR on myeloid cells limit autoimmunity in the central nervous system. Immunity 2008 28 : 675 686.
94. Chang EY, Guo B, Doyle SE, Cheng G. Cutting edge: involvement of the type I IFN production and signaling pathway in lipopolysaccharide-induced IL-10 production. J Immunol 2007 178 : 6705 6709.
95. Remoli ME, Gafa V, Giacomini E, Severa M, Lande R, Coccia EM. IFN-beta modulates the response to TLR stimulation in human DC: involvement of IFN regulatory factor-1 (IRF-1) in IL-27 gene expression. Eur J Immunol 2007 37 : 3499 3508.
96. Molle C, Nguyen M, Flamand V, Renneson J, Trottein F, De Wit D et al. IL-27 synthesis induced by TLR ligation critically depends on IFN regulatory factor 3. J Immunol 2007 178 : 7607 7615.
97. Shinohara ML, Kim JH, Garcia VA, Cantor H. Engagement of the type I interferon receptor on dendritic cells inhibits T helper 17 cell development: role of intracellular osteopontin. Immunity 2008 29 : 68 78.